Medscape www.medscape.com

References for:
The Diagnosis and Management of Vulvar Cancer

[Medscape Hematology-Oncology eJournal 1(2), 1998. © 1998 Medscape Portals, Inc]

  1. Parker SL, Tong T, Bolden S, et al: Cancer Statistics, 1997. CA Cancer J Clin 47:5, 1997.
  2. Sturgeon SR, Brinton LA, Devesa SS, et al: In situ and invasive vulvar cancer incidence trends (1973-1987). Am J Obstet Gynecol 166:1482, 1992.
  3. Eifel PJ, Berek JS, Thigpen JT: Cancer of the cervix, vagina, and vulva, in Devita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 5. Philadelphia, Lippincott-Raven Publishers, 1997, pp 1433-1478.
  4. Brinton LA, Nasca PC, Mallin K, et al: Case-control study of cancer of the vulva. Obstet Gynecol 75:859, 1990.
  5. Ansink AC, Krul MR, De Weger RA, et al: Human papillomavirus, lichen sclerosis, and squamous cell carcinoma of the vulva: Detection and prognostic significance. Gynecol Oncol 52:180, 1994.
  6. Bloss JD, Liao SY, Wilczynski SP, et al: Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: Evidence that squamous cell carcinoma of the vulva has more than one etiology. Hum Pathol 22:711, 1991.
  7. Crum CP: Carcinoma of the vulva: Epidemiology and pathogenesis. Obstet Gynecol 79:448, 1992.
  8. Hording U, Junge J, Daugaard S, et al: Vulvar squamous cell carcinoma and papillomaviruses: Indications for two different etiologies. Gynecol Oncol 52:241, 1994.
  9. Monk BJ, Burger RA, Lin F, et al: Prognostic significance of human papillomavirus (HPV) DNA in primary invasive vulvar cancer. Obstet Gynecol 85:709, 1995.
  10. Toki T, Kurman RJ, Park JS, et al: Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: A clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 10:107, 1991.
  11. Andersen WA, Franquemont DW, Williams H, et al: Vulvar squamous cell carcinoma and papillomaviruses: Two separate entities. Am J Obstet Gynecol 165:329, 1991.
  12. Kurman RJ, Toki T, Schiffman MH: Basaloid and warty carcinoma of the vulva. Am J Surg Pathol 17:133, 1993.
  13. Trimble CL, Hildesheim A, Brinton LA, et al: Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 87:59, 1996.
  14. Plentl AA, Friedman EA: Clinical significance of vulvar lymphatics, in Plentl AA, Friedman EA (eds): Lymphatic System of the Female Genitalia. Philadelphia, WB Saunders, 1971, pp 27-50.
  15. Shimm DS, Fuller AF, Orlow EL, et al: Prognostic variables in the treatment of squamous cell carcinoma of the vulva. Gynecol Oncol 24:343, 1986.
  16. Andreasson B, Nyboe J: Predictive factors with reference to low-risk of metastases in squamous cell carcinoma in the vulvar region. Gynecol Oncol 21:196, 1985.
  17. Hacker NF: Surgery for malignant tumors of the vulva, in Gershenson DM, DeCherney AH, Curry SL (eds): Operative Gynecology. Philadelphia, WB Saunders Company, 1993, pp 173-200.
  18. Parry-Jones E: Lymphatics of the vulva. J Obstet Gynecol Br Empire 70:751, 1963.
  19. Iversen T, Aas M: Lymph drainage from the vulva. Gynecol Oncol 16:179, 1983.
  20. Parker RT, Duncan I, Rampone J, et al: Operative management of early invasive epidermoid carcinoma of the vulva. Am J Obstet Gynecol 123:349, 1975.
  21. Hacker NF, Nieberg RK, Berek JS, et al: Superficially invasive vulvar cancer with nodal metastases. Gynecol Oncol 15:65, 1983.
  22. Chu J, Tamimi HK, Figge DC: Femoral node metastases with negative superficial inguinal nodes in early vulvar cancer. Am J Obstet Gynecol 140:337, 1981.
  23. Rutledge F, Smith JP, Franklin EW: Carcinoma of the vulva. Am J Obstet Gynecol 196:1117, 1970.
  24. Homesley HD, Bundy BM, Sedlis A, et al: Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (A Gynecologic Oncology Group study). Gynecol Oncol. 49:279, 1993.
  25. Binder SW, Huang I, Fu YS, et al: Risk factors for the development of lymph node metastasis in vulvar squamous carcinoma. Gynecol Oncol 37:9, 1990.
  26. Ross MJ, Ehrmann RL: Histologic prognosticators in stage I squamous cell carcinoma of the vulva. Obstet Gynecol 70:774, 1987.
  27. Hoffman JS, Kumar NB, Morley GW: Microinvasive squamous carcinoma of the vulva: Search for a definition. Obstet Gynecol 61:615, 1983.
  28. Hacker NF, Berek JS, Lagasse LD, et al: Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 63:155, 1984.
  29. Magrina JF, Webb MJ, Gaffey TA, et al: Stage I squamous cell cancer of the vulva. Am J Obstet Gynecol 134:453, 1979.
  30. Iversen T, Abeler V, Aalders J: Individualized treatment of stage I carcinoma of the vulva. Obstet Gynecol 57:85, 1981.
  31. Wilkinson EJ, Rico MJ, Pierson KK: Microinvasive carcinoma of the vulva. Int J Gynecol Pathol 1:29, 1982.
  32. Boice CR, Seraj IM, Thrasher T, et al: Microinvasive squamous carcinoma of the vulva: Present status and reassessment. Gynecol Oncol 18:71, 1984.
  33. Rowley K, Gallion HH, Donaldson ES, et al: Prognostic factors in early vulvar cancer. Gynecol Oncol 31:43, 1988.
  34. Struyk APHB, Bouma JJ, van Lindert ACM, et al: Early stage cancer of the vulva: A pilot investigation on cancer of the vulva in gynecologic oncology centers in the Netherlands. Proc Int Gynecol Cancer Soc 2:303, 1989.
  35. Wilkinson EJ: Premalignant and malignant tumors of the vulva, in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract, ed 4. New York, Springer-Verlag, 1994, pp 87-129.
  36. Friedrich EG, Wilkenson EJ, Fu YS: Carcinoma in situ of the vulva: A continuing challenge. Am J Obstet Gynecol 136:830, 1980.
  37. Bernstein SG, Kovac BR, Townsend DE, et al: Vulvar carcinoma in situ. Obstet Gynecol 61:304, 1983.
  38. Burke TW, Eifel P, McGuire W, et al: Vulva, in Hoskins WJ, Perez CA, Young RC (eds): Principles and Practice of Gynecologic Oncology, ed 2. Philadelphia, Lippincott-Raven Publishers, 1997, pp 717-751.
  39. Hart WR, Millman RB: Progression of intraepithelial Paget's disease of the vulva to invasive carcinoma. Cancer 40:2333, 1977.
  40. Palladino VS, Duffy JL, Bures GJ: Basal cell carcinoma of the vulva. Cancer 24:460, 1969.
  41. Benedet JL, Miller DM, Ehlen TG, et al: Basal cell carcinoma of the vulva: Clinical features and treatment results in 28 patients. Obstet Gynecol 90:765, 1997.
  42. Tavassoli FA, Norris HJ: Smooth muscle tumors of the vulva. Obstet Gynecol 53:213, 1979.
  43. Homesley HD, Bundy BN, Sedlis A, et al: Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group study). Am J Obstet Gynecol 164:997, 1991.
  44. Sedlis A, Homesley H, Bundy BN, et al: Positive groin lymph nodes in superficial squamous cell vulvar cancer (A Gynecologic Oncology Group study). Am J Obstet Gynecol 156:1159, 1987.
  45. Rutledge FN, Mitchell MF, Munsell MF, et al: Prognostic indicators for invasive carcinoma of the vulva. Gynecol Oncol 42:239, 1991.
  46. van der Velden J, van Lindert ACM, Lammes FB, et al: Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 75:2885, 1995.
  47. Clark WH, From L, Bernardino EA, et al: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705, 1969.
  48. Chung AF, Woodruff JM, Lewis JL: Malignant melanoma of the vulva: A report of 44 cases. Obstet Gynecol 45:638, 1975.
  49. Breslow A: Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902, 1970.
  50. Phillips GL, Bundy BN, Okagaki T, et al: Malignant melanoma of the vulva treated by radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Cancer 73:2626, 1994.
  51. Curtin JP, Saigo P, Slucher B, et al: Soft- tissue sarcoma of the vagina and vulva: A clinicopathologic study. Obstet Gynecol 86:269, 1995.
  52. Nirenberg A, Östör AG, Slavin J, et al: Primary vulvar sarcomas. Int J Gynecol Pathol 14:55, 1995.
  53. Creasman WT: New gynecologic cancer staging. Gynecol Oncol 58:157, 1995.
  54. Fleming ID, Cooper JS, Henson DE, et al (eds): AJCC Cancer Staging Manual, ed 5. Philadelphia, Lippincott-Raven Publishers, 1997, pp 181-184.
  55. Blair-Bell W, Datnow MM: Primary malignant diseases of the vulva, with special reference to treatment by operation. J Obstet Gynaecol Br Emp 43:755, 1996.
  56. Way S: The anatomy of the lymphatic drainage of the vulva and its influence on the radical operation for carcinoma. Ann R Coll Surg Engl 3:187, 1948.
  57. Basset A: Traitement chirurgical operatoire de l'epithelioma primifif du clitoris. Indications-technique-results. Rev Chir 46:546, 1912.
  58. Taussig FJ: Cancer of the vulva: an analysis of 155 cases. Am J Obstet Gynecol 40:764, 1940.
  59. Way S: Carcinoma of the vulva. Am J Obstet Gynecol 79:692, 1960.
  60. Andersen BL, Hacker NF. Psychological adjustment after vulvar surgery. Obstet Gynecol 63:155, 1984.
  61. Morrow CP, Curtin JP: Surgery for vulvar neoplasia, in Morrow CP, Curtin JP (eds): Gynecologic Cancer Surgery. New York, Churchill Livingstone Inc, 1996, pp 381-450.
  62. Bucema J, Woodruff JD: Progressive histobiologic alterations in the development of vulvar cancer. Am J Obstet Gynecol 138:146, 1980.
  63. Hording U, Junge J, Poulsen H, et al: Vulvar intraepithelial neoplasia III: A viral disease of undetermined progressive potential. Gynecol Oncol 56:276, 1995.
  64. Jones RW, Rowan DM: Vulvar intraepithelial neoplasia III: A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol 84:741, 1994.
  65. Hacker NF: Vulvar cancer, in Berek JS, Hacker NF (eds): Practical Gynecologic Oncology. Baltimore, Williams & Wilkins, 1994, pp 403-439.
  66. Gunn RA, Gallager HS: Vulvar Paget's disease: A topographic study. Cancer. 1980;46:590.
  67. Green TH Jr, Ulfelder H, Meigs JV: Epidermoid carcinoma of the vulva: An analysis of 238 cases. Parts I and II. Am J Obstet Gynecol 73:834, 1958.
  68. Hacker NF, Leuchter RS, Berek JS, et al: Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 58:574, 1981.
  69. Christophersen W, Buchsbaum HJ, Voet R, et al: Radical vulvectomy and bilateral groin lymphadenectomy utilizing separate groin incisions: Report of a case with recurrence in the intervening skin bridge. Gynecol Oncol 21:247, 1985.
  70. Schulz MJ, Penalver M: Recurrent vulvar carcinoma in the intervening tissue bridge in early invasive stage I disease treated by radical vulvectomy and bilateral groin dissection through separate incisions. Gynecol Oncol 35:383, 1989.
  71. Grimshaw RN, Murdoch JB, Monahan JM: Radical vulvectomy and bilateral ingino-femoral lymphadenectomy through separate incisions - experience with 100 cases. Int J Gynecol Cancer 3:18, 1993.
  72. Heaps JM, Yao YS, Montz FJ, et al: Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38:309, 1990.
  73. Hacker NF, van der Velden J: Conservative management of early vulvar cancer. Cancer 71:1673, 1993.
  74. Stehman FB, Bundy BN, Thomas G, et al: Groin dissection versus groin radiation in carcinoma of the vulva: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 24:39, 1992.
  75. Stehman FB, Bundy BN, Dvoretsky PM, et al: Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: A prospective study of the Gynecologic Oncology Group. Obstet Gynecol 79:490, 1992.
  76. Homesly HD, Bundy BN, Sedlis A, et al: Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68:733, 1986.
  77. Hacker NF, Berek JS, Lagasse LD, et al: Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 408, 1983.
  78. Thomas GM, Dembo AJ, Bryson SCP, et al: Changing concepts in the management of vulvar cancer. Gynecol Oncol 42:9, 1991.
  79. Curry SL, Wharton JT, Rutledge F: Positive lymph nodes in vulvar squamous carcinoma. Gynecol Oncol 9:63, 1980.
  80. Burke TW, Levenbach C, Coleman RL, et al: Surgical therapy of T1 and T2 vulvar carcinoma: Further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 57:215, 1995.
  81. Byron RL, Mishell DR, Yonemoto RH: The surgical treatment of invasive carcinoma of the vulva. Surg Gynecol Obstet 121:1243, 1965.
  82. Cavanagh D, Hoffman MS: Controversies in the management of vulvar carcinoma. Br J Obstet Gynecol 103:293, 1996.
  83. Hopkins MP, Morley GW: Pelvic exenteration for the treatment of vulvar cancer. Cancer 70:2835, 1992.
  84. Miller B, Morris M, Levenback C, et al: Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 58:202, 1995.
  85. Boronow RC, Hickman BT, Reagan MT, et al: Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications and dosimetric and surgical considerations. Am J Clin Oncol 10:171, 1987.
  86. Thomas G, Dembo A, DePetrillo A, et al: Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 34:263, 1989.
  87. Moore DH, Montana GS, Bundy BN, et al: Preoperative chemoradiation for advanced vulvar cancer: A phase II study of the Gynecologic Oncology Group. 27th Ann Proc SGO, 1996.
  88. Homesley H: Management of vulvar cancer. Cancer 76:2159, 1995.
  89. Deppe G, Brucker HW, Cohen CJ: Adriamycin treatment of advanced vulvar carcinoma. Obstet Gynecol 50:13, 1977.
  90. Trope C, Johnsson JE, Larsson G, et al: Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep 64:639, 1980.
  91. Belinson JL, Stewart JA, Richards A, et al: Bleomycin, vincristine, mitomycin C, and cisplatin in the management of gynecologic squamous cell cancer. Gynecol Oncol 20:387, 1985.
  92. Durrant KR, Mangione C, Lacave AJ, et al: Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: A phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol 37:359, 1990.
  93. Rose PG, Piver MS, Tsukada Y, et al: Conservative therapy for melanoma of the vulva. Am J Obstet Gynecol 159:52, 1988.
  94. Trimble EL, Lewis JL Jr, Williams LL, et al: Management of vulvar melanoma. Gynecol Oncol 45:254, 1992.
  95. Davidson T, Kissin M, Wesbury G: Vulvovaginal melanoma - should radical surgery be abandoned? Br J Obstet Gynecol 94:473, 1987.
  96. Balch CM: The role of elective lymph node dissection in melanoma: Rationale, results and controversies. J Clin Oncol 6:163, 1988.
  97. Habermalz HJ, Fischer JJ: Radiation therapy of malignant melanoma: Experience with high individual treatment doses. Cancer 38:2258, 1976.
  98. Ragnarsson-Olding B, Johansson H, Rutqvist LE, et al: Malignant melanoma of the vulva and vagina: Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 71:1893, 1993.
  99. Weinstock MA: Malignant melanoma of the vulva and vagina in the United States: Patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 171:1225, 1994.
  100. Copeland LJ, Sneige N, Gershenson DM, et al: Bartholin gland carcinoma. Obstet Gynecol 67:794, 1986.
  101. Leuchter RS, Hacker NF, Voet RL, et al: Primary carcinoma of the Bartholin gland: A report of 14 cases and a review of the literature. Obstet Gynecol 60:361, 1982.
  102. Breen JL, Neubecker RD, Greenwald E, et al: Basal cell carcinoma of the vulva. Obstet Gynecol 46:122, 1975.
  103. Hoffman JS, Roberts WS, Ruffolo EH: Basal cell carcinoma of the vulva with inguinal node metastases. Gynecol Oncol 29:113, 1988.
  104. Stehman FB, Bundy BN, Ball H, et al: Sites of failure and times to failure in carcinoma of the vulva treated conservatively: A Gynecologic Oncology Group study. Am J Obstet Gynecol 174:1128, 1996.
  105. Sturgeon SR, Curtis RE, Johnson K, et al: Second primary cancers after vulvar and vaginal cancers. Am J Obstet Gynecol 174:929, 1996.